New Drugs FDA Approves Sarclisa (isatuximab-irfc) for Patients with Relapsed Refractory Multiple Myeloma 6 years ago
Healthcare News Experiment Shows Awareness Of Dreaded Deadlines Improves Cognitive Performance 6 years ago